|
SAMMPRIS Data Review Fails to Find ‘Smoking Gun’ Behind Strokes
An analysis of data from a pivotal trial of Stryker’s Wingspan Stent that was aborted due to a high stroke rate failed to find a single “smoking gun” behind the adverse events and likely won’t lead to a reconsideration of the FDA’s recent use restrictions, one expert says.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives